Below are the most recent publications written about "Bone Density Conservation Agents" by people in Profiles.
-
Stoffers AJ, Mancilla EE, Levine MA, Mayer M, Monk HM, Rosano J, Weber DR. Clinical Efficacy of Zoledronic Acid on Fracture Reduction in Youth With Primary and Secondary Skeletal Fragility. J Clin Endocrinol Metab. 2025 Jun 17; 110(7):2031-2040.
-
Girdler SJ, Lindsey MH, Sebastian AS, Nassr A. Osteoporosis Evaluation and Management in Spine Surgery. J Am Acad Orthop Surg. 2024 Sep 15; 32(18):e909-e918.
-
Hori Y, McDonald TC, Thornley P, Almeida da Silva LC, Kaymaz B, Rogers KJ, Yorgova PK, Bober MB, Carroll R, Kruse RW, Franzone JM, Shah SA. Midterm Outcomes of Multimodal Approach to Treating Severe Scoliosis in Patients With Osteogenesis Imperfecta. J Am Acad Orthop Surg. 2024 Sep 15; 32(18):e951-e960.
-
Mikula AL, Lakomkin N, Hamouda AM, Everson MC, Pennington Z, Kumar R, Pinter ZW, Martini ML, Bydon M, Kennel KA, Baffour F, Nassr A, Freedman B, Sebastian AS, Abode-Iyamah K, Anderson PA, Fogelson JL, Elder BD. Change in spinal bone mineral density as estimated by Hounsfield units following osteoporosis treatment with romosozumab, teriparatide, denosumab, and alendronate: an analysis of 318 patients. J Neurosurg Spine. 2024 09 01; 41(3):309-315.
-
Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, Shamliyan TA, Cooney TG, Balk E, Cross JT, Fitterman N, Lin JS, Maroto M, Miller MC, Obley AJ, Owens DK, Shekelle PG, Tice JA, Tufte JE, Yost J. Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert). Ann Intern Med. 2024 06; 177(6):eL230113.
-
Almeida Da Silva LC, Kaymaz B, Hori Y, Montufar Wright PE, Rogers KJ, Trionfo A, Howard JJ, Bowen JR, Shrader MW, Miller F. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management. J Pediatr Orthop B. 2024 Jul 01; 33(4):407-410.
-
Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, Shamliyan T, Cooney TG, Cross JT, Fitterman N, Lin JS, Maroto M, Obley AJ, Tice JA, Tufte JE. Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians. Ann Intern Med. 2023 02; 176(2):224-238.
-
Villavisanis DF, Schmidt RJ, Napoli JA. Pediatric Maxillary Giant Cell Tumors: Surgical Management by Transoral and Endoscopic Transnasal Enucleation and Curettage. J Craniofac Surg. 2022 Oct 01; 33(7):e747-e750.
-
Van Poznak C, Reynolds EL, Estilo CL, Hu M, Schneider BP, Hertz DL, Gersch C, Thibert J, Thomas D, Banerjee M, Rae JM, Hayes DF. Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer. Oral Dis. 2022 Jan; 28(1):193-201.
-
Sawamoto K, ?lvarez JV, Herre?o AM, Otero-Espinar FJ, Couce ML, Alm?ciga-D?az CJ, Tomatsu S. Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders. Curr Osteoporos Rep. 2020 10; 18(5):515-525.